Literature DB >> 6132593

Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Surgical experience.

J A van Heerden, R B Kent, G W Sizemore, C S Grant, W H ReMine.   

Abstract

Forty-five patients with biochemically documented primary hyperparathyroidism as part of multiple endocrine neoplasia syndrome types 1 or 2 were surgically treated from 1960 through 1980. Hyperplasia occurred in 69% of the patients, single adenoma in 27%, and double adenomas in 4%. All but two patients with hyperplasia underwent subtotal parathyroidectomy. In this group, the cure rate was 93% and the incidence of permanent postoperative hypoparathyroidism 23%. In the adenoma group, treatment included excision of the adenoma and biopsy of at least one other gland. The cure rate was 76%, with no postoperative hypoparathyroidism. Analysis of patients with persistent hyperparathyroidism suggested that failure to recognize multiple gland disease was the principal cause of postoperative hypercalcemia. In view of the high incidence of hypocalcemia after subtotal parathyroidectomy, approximately 500 mg of tissue should be cryopreserved to allow transplantation should hypocalcemia ensue postoperatively.

Entities:  

Mesh:

Year:  1983        PMID: 6132593     DOI: 10.1001/archsurg.1983.01390050017003

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  Thymic carcinoid and parathyroid hyperplasia detection with 99mTc-MIBI men type 1.

Authors:  C Marí; J León; J Farrerons; X Matis-Guiu; A Tembl; J C Martin; A Flotats; L l Bernà
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

2.  Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: choice of surgical procedure.

Authors:  J Malmaeus; L Benson; H Johansson; S Ljunghall; J Rastad; G Akerström; K Oberg
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome.

Authors:  Francesco Tonelli; Carlo Biagini; Francesco Giudici; Federica Cioppi; Maria Luisa Brandi
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

4.  Management of primary hyperparathyroidism caused by multiple gland disease.

Authors:  P E Goretzki; C Dotzenrath; H D Roeher
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

5.  Localization procedures in patients requiring reoperation for hyperparathyroidism.

Authors:  O H Clark; D D Stark; G A Gooding; A A Moss; S B Arnaud; T H Newton; D Norman; W O Bank; C D Arnaud
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

6.  Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy.

Authors:  S Tezelman; W Shen; J K Shaver; A E Siperstein; Q Y Duh; H Klein; O H Clark
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

7.  Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1.

Authors:  P Hellman; B Skogseid; C Juhlin; G Akerström; J Rastad
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

8.  Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

Authors:  Jeffrey A Norton; David J Venzon; Marc J Berna; H R Alexander; Douglas L Fraker; Stephen K Libutti; Stephen J Marx; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

Review 9.  Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy.

Authors:  Francesco Tonelli; Francesco Giudici; Tiziana Cavalli; Maria Luisa Brandi
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.